Response of metastatic acral melanoma with exon 11 <i>BRAF</i> G469A mutation to BRAF/MEK inhibition-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Response of metastatic acral melanoma with exon 11 BRAF G469A mutation to BRAF/MEK inhibition

Published:2022-02-26 Issue:4 Volume:20 Page:528-530
ISSN:1610-0379
Container-title:JDDG: Journal der Deutschen Dermatologischen Gesellschaft
language:en
Short-container-title:J Deutsche Derma Gesell

Author:

Julius Katharina¹,Kromer Christian¹,Schnabel Viktor¹,Vlahova Lyubomira¹,Kitz Julia²,Schön Michael P.¹³,Sahlmann Carsten‐Oliver⁴,Kretschmer Lutz¹

Affiliation:

1. Department of Dermatology Venereology and Allergology University Medical Center Göttingen Germany

2. Institute of Pathology University Medical Center Göttingen Germany

3. Lower Saxony Institute of Occupational Dermatology University Medical Center Göttingen Germany

4. Institute of Nuclear Medicine University Medical Center Göttingen Germany

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ddg.14737

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of trametinib in a metastatic urothelial carcinoma patient with a BRAF mutation;IJU Case Reports;2024-07-10

2. Response to Dabrafenib Plus Trametinib in a Patient With an Uncommon Activating BRAF Mutation: A First in Non–Small Cell Lung Cancer;Journal of the National Comprehensive Cancer Network;2024-04

3. Ipilimumab/nivolumab/pembrolizumab;Reactions Weekly;2022-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP